Weiwen Xu

901 total citations
39 papers, 725 citations indexed

About

Weiwen Xu is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Weiwen Xu has authored 39 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Weiwen Xu's work include Glycosylation and Glycoproteins Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Cancer, Stress, Anesthesia, and Immune Response (4 papers). Weiwen Xu is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Cancer, Stress, Anesthesia, and Immune Response (4 papers). Weiwen Xu collaborates with scholars based in China, Hong Kong and Cayman Islands. Weiwen Xu's co-authors include Qiang Ma, Yingsong Wu, Congrong Wang, Yan Geng, Chunmei Xie, Wei-Bing Song, Bingling Li, Jie Fan, Ming Li and Wei Zhu and has published in prestigious journals such as Hepatology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Weiwen Xu

37 papers receiving 715 citations

Peers

Countries citing papers authored by Weiwen Xu

Since Specialization

Citations

This map shows the geographic impact of Weiwen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwen Xu more than expected).

Fields of papers citing papers by Weiwen Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwen Xu. The network helps show where Weiwen Xu may publish in the future.

Co-authorship network of co-authors of Weiwen Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwen Xu. A scholar is included among the top collaborators of Weiwen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwen Xu. Weiwen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Auto-Arena: Automating LLM Evaluations with Agent Peer Battles and Committee Discussions 2025 ·(unknown), (unknown), Yew Ken Chia, Weiwen Xu, (unknown), Lidong Bing	1
2	Chain of Ideas: Revolutionizing Research Via Novel Idea Development with LLM Agents 2025 ·Long Li, Weiwen Xu, (unknown), R. P. Zhao, (unknown), (unknown), Bo Zhang, Yuming Jiang, Yu Xin, Ruili Dang, Yu Rong, Deli Zhao, Feng Tian, Lidong Bing	0
3	PeerDA: Data Augmentation via Modeling Peer Relation for Span Identification Tasks 2023 ·Weiwen Xu, Xin Li, (unknown), Wai Lam, Lidong Bing	5
4	mPMR: A Multilingual Pre-trained Machine Reader at Scale 2023 ·Weiwen Xu, Xin Li, Wai Lam, Lidong Bing	2
5	ConReader: Exploring Implicit Relations in Contracts for Contract Clause Extraction 2022 ·Weiwen Xu, (unknown), Wenqiang Lei, Wenlong Zhao, Tat‐Seng Chua, Wai Lam	2
6	Targeting SGK1 enhances the efficacy of radiotherapy in locally advanced rectal cancer 2020 ·Biomedicine & Pharmacotherapy ·(unknown), Weiwei Xiao, Ting Jiang, Zhiwei Guo, Min Li, Hui Chang, Ying-Song Wu, Minshan Chen, Mude Shi, Weiwen Xu, Yuanhong Gao	9
7	Diagnostic value of glypican-3, arginase-1 and hepatocyte paraffin antigen -1 in differentiating hepatocellular carcinoma from intrahepatic cholangiocarcinoma 2020 ·Translational Cancer Research ·Congrong Wang, (unknown), Xuanyu Zhang, Chunmei Xie, (unknown), Xiao Xu, Jian Yang, Yu Li, Weiwen Xu	5
8	Noninvasive Prenatal Testing of Rare Autosomal Aneuploidies by Semiconductor Sequencing 2018 ·DNA and Cell Biology ·(unknown), Zhikun Liang, (unknown), Weiwen Xu, Yingsong Wu, Xuexi Yang, Ming Li	2
9	Development of an Affimer-antibody combined immunological diagnosis kit for glypican-3 2017 ·Scientific Reports ·Chunmei Xie, Christian Tiede, (unknown), Congrong Wang, Zhixiong Li, Xiao Xu, Michael J. McPherson, Darren C. Tomlinson, Weiwen Xu	30
10	Development of a Time-Resolved Fluorescence Immunoassay for the Diagnosis of Hepatocellular Carcinoma Based on the Detection of Glypican-3 2017 ·Journal of Fluorescence ·Juanjuan Chen, Chunmei Xie, Congrong Wang, Yong Wan, (unknown), Ming Li, Weiwen Xu	24
11	Evaluation of the Analytical and Clinical Performances of Time-Resolved Fluoroimmunoassay for Detecting Carcinoma Antigen 50 2014 ·Journal of Immunoassay and Immunochemistry ·(unknown), (unknown), Jianfeng Hang, (unknown), (unknown), Ping Xu, (unknown), Weiwen Xu	10
12	Clinical application of specific antibody against glypican-3 for hepatocellular carcinoma diagnosis 2013 ·Science China Life Sciences ·(unknown), Qiang Ma, Bin Zhang, (unknown), Xiguang Xu, Mingsong Li, Weiwen Xu, Ming Li	16
13	Development of an amplified luminescent proximity homogeneous assay for quantitative determination of hepatitis B surface antigen in human serum 2013 ·Clinica Chimica Acta ·Tiancai Liu, He Huang, (unknown), An He, Ming Li, Yingsong Wu, Weiwen Xu	22
14	A Monoclonal Antibody Against a Potential Cancer Biomarker, Human Ubiquitin-Conjugating Enzyme E2 2012 ·Hybridoma ·Hongyan Du, Ligang Jie, Weiwen Xu, Yingsong Wu, Tiancai Liu, Ming Li	4
15	RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway 2011 ·Hepatology ·Suihai Wang, Xiang Huang, Yue Li, (unknown), Ying Zhang, Huimin Dong, Weiwen Xu, Jiliang Li, (unknown)	33
16	Preparation and Characterization of Monoclonal Antibody Against Translationally Controlled Tumor Protein 2011 ·Hybridoma ·Qiang Ma, Fenfang Wu, (unknown), Wen Shu, (unknown), (unknown), Weiwen Xu, Ming Li	0
17	Aberrant CpG Island Hypermethylation and Down-Regulation of Oct-6 mRNA Expression in Human Hepatocellular Carcinoma 2011 ·Digestive Diseases and Sciences ·(unknown), Xuexi Yang, Xianghong Li, Weiwen Xu, Ying Wang, Wei Zhu, Ming Li	3
18	Evaluation index for in vitro diagnostic products(IVD) during R&D 2010 ·Weiwen Xu	1
19	PSMA7, A Potential Biomarker of Diseases 2009 ·Protein and Peptide Letters ·Hongyan Du, Xiang Huang, Suihai Wang, Yingsong Wu, Weiwen Xu, Ming Li	23
20	The Role of Translationally Controlled Tumor Protein in Tumor Growth and Metastasis of Colon Adenocarcinoma Cells 2009 ·Journal of Proteome Research ·Qiang Ma, (unknown), Weiwen Xu, Yingsong Wu, (unknown), Wen Shu, (unknown), Hongyan Du, Ming Li	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact